Open innovation for new drug research in Indian pharmaceutical sector

Bhawani Bhatnagar; Jillian MacBryde; Viktor Dörfler

Open innovation for new drug research in Indian pharmaceutical sector

Bhawani Bhatnagar, Jillian MacBryde, Viktor Dörfler

Management Science

Research output: Contribution to conference › Poster › peer-review

60 Downloads (Pure)

Abstract

The national environment in India for the pharmaceutical sector recently underwent changes with The Patents (Amendment)Act 2005, to comply with the TRIPS agreement leading to product patent protection.This has led to Government initiatives to support R&D and promote interlinkages between industry and academia. Globally, innovation ecosystem in recent years has morphed and seen a paradigm shift from a closed innovation in-house R&D model to more open approaches. In this context, the study aspires to gain an understanding of how the institutional and regulatory factors influence adoption of open innovation strategies at firm level and enables formation of innovation networks between universities, public research labs and firms in India.

Original language	English
Publication status	Published - 12 Sep 2014
Event	Drug Discovery India 2014 - Ramada Powai Hotel & Convention Centre, Mumbai, India Duration: 11 Sep 2014 → 12 Sep 2014

Conference

Conference	Drug Discovery India 2014
Country	India
City	Mumbai
Period	11/09/14 → 12/09/14

Keywords

innovation
collaboration
pharmaceutics

Access to Document

Bhatnagar-etal-DDI2014-open-innovation-for-new-drug-researchAccepted author manuscript, 514 KB

Conference website

Cite this

@conference{b69dd7d1b58a446c8ca180bacc6e5e5e,

title = "Open innovation for new drug research in Indian pharmaceutical sector",

abstract = "The national environment in India for the pharmaceutical sector recently underwent changes with The Patents (Amendment)Act 2005, to comply with the TRIPS agreement leading to product patent protection.This has led to Government initiatives to support R&D and promote interlinkages between industry and academia. Globally, innovation ecosystem in recent years has morphed and seen a paradigm shift from a closed innovation in-house R&D model to more open approaches. In this context, the study aspires to gain an understanding of how the institutional and regulatory factors influence adoption of open innovation strategies at firm level and enables formation of innovation networks between universities, public research labs and firms in India.",

keywords = "innovation, collaboration, pharmaceutics",

author = "Bhawani Bhatnagar and Jillian MacBryde and Viktor D{\"o}rfler",

year = "2014",

month = sep,

day = "12",

language = "English",

note = "Drug Discovery India 2014 ; Conference date: 11-09-2014 Through 12-09-2014",

}

TY - CONF

T1 - Open innovation for new drug research in Indian pharmaceutical sector

AU - Bhatnagar, Bhawani

AU - MacBryde, Jillian

AU - Dörfler, Viktor

PY - 2014/9/12

Y1 - 2014/9/12

N2 - The national environment in India for the pharmaceutical sector recently underwent changes with The Patents (Amendment)Act 2005, to comply with the TRIPS agreement leading to product patent protection.This has led to Government initiatives to support R&D and promote interlinkages between industry and academia. Globally, innovation ecosystem in recent years has morphed and seen a paradigm shift from a closed innovation in-house R&D model to more open approaches. In this context, the study aspires to gain an understanding of how the institutional and regulatory factors influence adoption of open innovation strategies at firm level and enables formation of innovation networks between universities, public research labs and firms in India.

AB - The national environment in India for the pharmaceutical sector recently underwent changes with The Patents (Amendment)Act 2005, to comply with the TRIPS agreement leading to product patent protection.This has led to Government initiatives to support R&D and promote interlinkages between industry and academia. Globally, innovation ecosystem in recent years has morphed and seen a paradigm shift from a closed innovation in-house R&D model to more open approaches. In this context, the study aspires to gain an understanding of how the institutional and regulatory factors influence adoption of open innovation strategies at firm level and enables formation of innovation networks between universities, public research labs and firms in India.

KW - innovation

KW - collaboration

KW - pharmaceutics

UR - http://selectbiosciences.com/conferences/index.aspx?conf=DDI14

M3 - Poster

T2 - Drug Discovery India 2014

Y2 - 11 September 2014 through 12 September 2014

ER -

Open innovation for new drug research in Indian pharmaceutical sector

Abstract

Conference

Keywords

Access to Document

Fingerprint

Cite this